nafamostat
Ligand Summary
inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic; RN given refers to parent cpd
UNII: Y25LQ0H97D
PubChem: 4413
Guide to Pharmacology: 4262
ChEMBL: CHEMBL273264
DrugCentral: 1867
LyCHI: TS79G7GAB2QX
Target Activities
36 Activities
Items per page:
10
1 – 10 of 36
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||